Biovail’s Ralivia receives approvable letter
Biovail has received an approvable letter from the FDA for the drug, but it has yet to be approved.
The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.
Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.
Hires and promotions for manufacturers, regulatory and agencies
The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.